Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2013-10-01 | Michael R. Dougherty, age 55, has served as a member of our Board of Directors since May 2013. ... Mr. Dougherty’s deep understanding of biotechnology finance, research and development, sales and marketing, strategy, and operations and his executive experience as chief executive officer at several biotechnology companies led to the conclusion that he should serve on the Company’s Board of Directors. ... Audit Committee Member. ... Compensation Committee Member. ... Director Compensation Table shows total compensation of $71,138. |
| 2014-10-03 | Michael R. Dougherty, age 56, has served as a member of the Company’s Board of Directors since May 2013. From May 2012 to October 2012, Mr. Dougherty was Chief Executive Officer and a member of the Board of Directors of Kalidex Pharmaceuticals, Inc. |
| 2015-09-30 | The members of the Company’s Audit Committee are Ms. VanLent (Chair), Mr. Dougherty and Mr. Richard. The members of the Compensation Committee are Dr. Fox (Chair), Mr. Dougherty and Dr. Cox. |
| 2016-09-27 | Michael R. Dougherty, age 58, has served as a member of the Company’s Board of Directors since May 2013. ... Mr. Dougherty’s broad understanding of key issues in the biotechnology industry, including finance, research and development, sales and marketing, strategy, and operations and his significant executive experience as a chief executive officer and/or director at several biotechnology companies led to the conclusion that he should serve on the Company’s Board of Directors. |
Data sourced from SEC filings. Last updated: 2025-07-01